Dave Fornell, DAIC Editor

Dave Fornell, editor of DAIC Magazine

Blog | Dave Fornell, DAIC Editor | May 11, 2015

Heart Rhythm Society Offers Updates on the Latest EP Technology

The Heart Rhythm Society’s 36th Annual Scientific Sessions, May 13-16, 2015 in Boston, will offer the latest clinical data and new technology updates in electrophysiology (EP). These include new information on leadless pacing, the impact of wireless remote device monitoring, the latest advances in atrial fibrillation management and shockless ICD implant evaluations. 

View the list of the HRS late-breaking trial presentations

One of the key technology trends I have seen in healthcare in the past year is the mass proliferation of consumer-grade wearable health monitoring devices and their integration with smartphone technology. These devices and their expected impact on healthcare and physician patient engagement were among the hottest topics at the American College of Cardiology (ACC) and the Healthcare Information and Management Systems Society (HIMSS) meetings earlier this year. HRS also has sessions that will discuss this evolution in patient involvement in their own care, including a “body computing” display at the EPicenter, Booth 535 on the expo floor. This area will show how digital health is impacting medicine with the convergence of sophisticated diagnostic sensors, innovative mobile applications and a powerful technology infrastructure.

HRS 2015 includes more than 250 educational sections and 130 exhibitors. HRS plans to highlight some of the key educational sessions with video posted online within 24 hours of the sessions. This offers a unique opportunity for medical professionals who are unable to attend the meeting, or those with scheduling conflicts, to view a selection of the state-of-the-art presentations. View the list of webcast presentations.

Below are some key technologies that will be discussed in sessions and on the expo floor.

Related Content

Abbott Secures FDA Approval for MRI Compatibility on Ellipse ICD
Technology | Implantable Cardioverter Defibrillator (ICD)| September 22, 2017
Abbott announced U.S. Food and Drug Administration (FDA) approval for magnetic resonance (MR)-conditional labeling for...
Fysicon Receives FDA Approval for QMAPP Hemodynamic Monitoring System
Technology | Hemodynamic Monitoring Systems| September 18, 2017
Fysicon announced that it has been granted 510(k) clearance by the U.S. Food and Drug Administration (FDA) for its...
Technavio Projects 9 Percent Global Growth for Electrophysiology Therapeutic Devices

Image courtesy of Technavio

News | EP Lab| September 11, 2017
September 11, 2017 — According to the latest market study released by Technavio, the global...
LAA closure during open heart surgery in the LAACS Study showed better outcomes for all patients.

LAA closure during open heart surgery in the LAACS Study showed better outcomes for all patients.

Feature | Left Atrial Appendage (LAA) Occluders| September 07, 2017
September 7, 2017 — Closure of the left atrial appendage (LAA) during heart surgery protects the brain, according to
EMANATE Trial Shows Apixaban Lowers stroke in AF Patients Undergoing Cardioversion.
News | Atrial Fibrillation| September 01, 2017
September 1, 2017 — Apixaban lowers the risk of stroke compared to warfarin in anticoagulation-naïve patients with at
CASTLE-AF Study shows Catheter Ablation of Atrial Fibrillation is First-Line Treatment for Heart Failure Patients. Biotronic Ilivia 7 ICD.

The CASTLE-AF Study shows catheter alation of AF can be used effectively to treat heart failure in patients with an implanted ICD.

News | Atrial Fibrillation| September 01, 2017
September 1, 2017 — Final results from the CASTLE-AF study show a 38 percent reduction in the composite of all-cause
Abbott. St. Jude Medical has updated its firmware to address cybersecurity issues with its Allure Quadra MP and other EP devices

Abbott. St. Jude Medical has updated its firmware to address cybersecurity issues with its Allure Quadra MP and other EP devices.

Feature | EP Lab| August 29, 2017 | Dave Fornell
August 29, 2017 — The U.S.
Real-World Analysis Compares Safety, Effectiveness of Apixaban Versus Warfarin
News | Antiplatelet and Anticoagulation Therapies| August 28, 2017
August 28, 2017 — Bristol-Myers Squibb Company and Pfizer Inc.
Biotronik Announces U.S. Launch of Edora HF-T QP CRT Pacemaker
Technology | Cardiac Resynchronization Therapy Devices (CRT)| August 21, 2017
Biotronik announced U.S. Food and Drug Administration (FDA) approval and commercial availability of Edora HF-T QP, an...
Overlay Init